MERCURY SYSTEMS INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that MERCURY SYSTEMS INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 27, 2025 | $912.02M | Aug 11, 2025 |
| FY2025 | Jun 28, 2024 | $835.28M | Aug 11, 2025 |
| FY2025 | Jun 30, 2023 | $973.88M | Aug 11, 2025 |
| FY2024 | Jul 1, 2022 | $988.20M | Aug 13, 2024 |
| FY2021 | Jul 2, 2021 | $250.84M | Aug 17, 2021 |
| FY2021 | Apr 2, 2021 | $256.86M | Aug 17, 2021 |
| FY2021 | Jan 1, 2021 | $210.68M | Aug 17, 2021 |
| FY2021 | Oct 2, 2020 | $205.62M | Aug 17, 2021 |
| FY2021 | Jul 3, 2020 | $217.38M | Aug 17, 2021 |
| FY2021 | Mar 27, 2020 | $208.02M | Aug 17, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 27, 2025 | $254.49M | Aug 11, 2025 |
| FY2025 | Jun 28, 2024 | $195.90M | Aug 11, 2025 |
| FY2025 | Jun 30, 2023 | $316.73M | Aug 11, 2025 |
| FY2024 | Jul 1, 2022 | $394.96M | Aug 13, 2024 |
| FY2021 | Jul 2, 2021 | $102.78M | Aug 17, 2021 |
| FY2021 | Apr 2, 2021 | $105.62M | Aug 17, 2021 |
| FY2021 | Jan 1, 2021 | $88.67M | Aug 17, 2021 |
| FY2021 | Oct 2, 2020 | $88.12M | Aug 17, 2021 |
| FY2021 | Jul 3, 2020 | $96.61M | Aug 17, 2021 |
| FY2021 | Mar 27, 2020 | $93.33M | Aug 17, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 27, 2025 | ($37.90M) | Aug 11, 2025 |
| FY2025 | Jun 28, 2024 | ($137.64M) | Aug 11, 2025 |
| FY2025 | Jun 30, 2023 | ($28.34M) | Aug 11, 2025 |
| FY2024 | Jul 1, 2022 | $11.28M | Aug 13, 2024 |
| FY2021 | Jul 2, 2021 | $17.93M | Aug 17, 2021 |
| FY2021 | Apr 2, 2021 | $15.64M | Aug 17, 2021 |
| FY2021 | Jan 1, 2021 | $12.69M | Aug 17, 2021 |
| FY2021 | Oct 2, 2020 | $15.80M | Aug 17, 2021 |
| FY2021 | Jul 3, 2020 | $27.22M | Aug 17, 2021 |
| FY2021 | Mar 27, 2020 | $23.57M | Aug 17, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 27, 2025 | ($19.63M) | Aug 11, 2025 |
| FY2025 | Jun 28, 2024 | ($147.75M) | Aug 11, 2025 |
| FY2025 | Jun 30, 2023 | ($21.69M) | Aug 11, 2025 |
| FY2024 | Jul 1, 2022 | $31.61M | Aug 13, 2024 |
| FY2021 | Jul 2, 2021 | $22.41M | Aug 17, 2021 |
| FY2021 | Apr 2, 2021 | $21.71M | Aug 17, 2021 |
| FY2021 | Jan 1, 2021 | $18.11M | Aug 17, 2021 |
| FY2021 | Oct 2, 2020 | $18.77M | Aug 17, 2021 |
| FY2021 | Jul 3, 2020 | $26.42M | Aug 17, 2021 |
| FY2021 | Mar 27, 2020 | $26.34M | Aug 17, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 27, 2025 | $67.65M | Aug 11, 2025 |
| FY2025 | Jun 28, 2024 | $101.33M | Aug 11, 2025 |
| FY2025 | Jun 30, 2023 | $108.80M | Aug 11, 2025 |
| FY2024 | Jul 1, 2022 | $107.17M | Aug 13, 2024 |
| FY2023 | Jul 2, 2021 | $113.48M | Aug 15, 2023 |
| FY2022 | Jul 3, 2020 | $98.49M | Aug 16, 2022 |
| FY2021 | Jun 30, 2019 | $68.93M | Aug 17, 2021 |
| FY2020 | Jun 30, 2018 | $58.81M | Aug 18, 2020 |
| FY2019 | Jun 30, 2017 | $54.09M | Aug 15, 2019 |
| FY2018 | Jun 30, 2016 | $36.39M | Aug 16, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 27, 2025 | $154.41M | Aug 11, 2025 |
| FY2025 | Jun 28, 2024 | $166.79M | Aug 11, 2025 |
| FY2025 | Jun 30, 2023 | $160.64M | Aug 11, 2025 |
| FY2024 | Jul 1, 2022 | $157.04M | Aug 13, 2024 |
| FY2023 | Jul 2, 2021 | $134.34M | Aug 15, 2023 |
| FY2022 | Jul 3, 2020 | $132.25M | Aug 16, 2022 |
| FY2021 | Jun 30, 2019 | $110.72M | Aug 17, 2021 |
| FY2020 | Jun 30, 2018 | $88.37M | Aug 18, 2020 |
| FY2019 | Jun 30, 2017 | $76.49M | Aug 15, 2019 |
| FY2018 | Jun 30, 2016 | $52.95M | Aug 16, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 27, 2025 | $138.85M | Aug 11, 2025 |
| FY2025 | Jun 28, 2024 | $60.38M | Aug 11, 2025 |
| FY2025 | Jun 30, 2023 | ($21.25M) | Aug 11, 2025 |
| FY2024 | Jul 1, 2022 | ($18.87M) | Aug 13, 2024 |
| FY2023 | Jul 2, 2021 | $97.25M | Aug 15, 2023 |
| FY2022 | Jul 3, 2020 | $115.18M | Aug 16, 2022 |
| FY2021 | Jun 30, 2019 | $97.52M | Aug 17, 2021 |
| FY2020 | Jun 30, 2018 | $43.32M | Aug 18, 2020 |
| FY2019 | Jun 30, 2017 | $59.15M | Aug 15, 2019 |
| FY2018 | Jun 30, 2016 | $36.94M | Aug 16, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 27, 2025 | $19.80M | Aug 11, 2025 |
| FY2025 | Jun 28, 2024 | $34.29M | Aug 11, 2025 |
| FY2025 | Jun 30, 2023 | $38.80M | Aug 11, 2025 |
| FY2024 | Jul 1, 2022 | $27.66M | Aug 13, 2024 |
| FY2023 | Jul 2, 2021 | $45.60M | Aug 15, 2023 |
| FY2022 | Jul 3, 2020 | $43.29M | Aug 16, 2022 |
| FY2021 | Jun 30, 2019 | $26.69M | Aug 17, 2021 |
| FY2020 | Jun 30, 2018 | $15.11M | Aug 18, 2020 |
| FY2019 | Jun 30, 2017 | $32.84M | Aug 15, 2019 |
| FY2018 | Jun 30, 2016 | $7.89M | Aug 16, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 27, 2025 | $2.43B | Aug 11, 2025 |
| FY2025 | Jun 28, 2024 | $2.38B | Aug 11, 2025 |
| FY2024 | Jun 30, 2023 | $2.39B | Aug 13, 2024 |
| FY2023 | Jul 1, 2022 | $2.30B | Aug 15, 2023 |
| FY2022 | Jul 2, 2021 | $1.96B | Aug 16, 2022 |
| FY2021 | Jul 3, 2020 | $1.61B | Aug 17, 2021 |
| FY2020 | Jun 30, 2019 | $1.42B | Aug 18, 2020 |
| FY2019 | Jun 30, 2018 | $1.06B | Aug 15, 2019 |
| FY2018 | Jun 30, 2017 | $815.75M | Aug 16, 2018 |
| FY2017 | Jun 30, 2016 | $736.50M | Aug 18, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 27, 2025 | $961.30M | Aug 11, 2025 |
| FY2025 | Jun 28, 2024 | $906.13M | Aug 11, 2025 |
| FY2024 | Jun 30, 2023 | $824.68M | Aug 13, 2024 |
| FY2023 | Jul 1, 2022 | $767.23M | Aug 15, 2023 |
| FY2022 | Jul 2, 2021 | $470.99M | Aug 16, 2022 |
| FY2021 | Jul 3, 2020 | $225.94M | Aug 17, 2021 |
| FY2020 | Jun 30, 2019 | $132.24M | Aug 18, 2020 |
| FY2019 | Jun 30, 2018 | $292.59M | Aug 15, 2019 |
| FY2018 | Jun 30, 2017 | $90.33M | Aug 16, 2018 |
| FY2017 | Jun 30, 2016 | $263.45M | Aug 18, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 27, 2025 | $1.47B | Aug 11, 2025 |
| FY2025 | Jun 28, 2024 | $1.47B | Aug 11, 2025 |
| FY2025 | Jun 30, 2023 | $1.57B | Aug 11, 2025 |
| FY2025 | Jul 1, 2022 | $1.54B | Aug 11, 2025 |
| FY2024 | Jul 2, 2021 | $1.48B | Aug 13, 2024 |
| FY2023 | Jul 3, 2020 | $1.38B | Aug 15, 2023 |
| FY2022 | Jun 30, 2019 | $1.28B | Aug 16, 2022 |
| FY2021 | Jun 30, 2018 | $771.89M | Aug 17, 2021 |
| FY2020 | Jun 30, 2017 | $725.42M | Aug 18, 2020 |
| FY2019 | Jun 30, 2016 | $473.04M | Aug 15, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 27, 2025 | $938.09M | Aug 11, 2025 |
| FY2025 | Jun 28, 2024 | $938.09M | Aug 11, 2025 |
| FY2024 | Jun 30, 2023 | $938.09M | Aug 13, 2024 |
| FY2023 | Jul 1, 2022 | $937.88M | Aug 15, 2023 |
| FY2022 | Jul 2, 2021 | $804.91M | Aug 16, 2022 |
| FY2021 | Jul 3, 2020 | $614.08M | Aug 17, 2021 |
| FY2020 | Jun 30, 2019 | $562.15M | Aug 18, 2020 |
| FY2019 | Jun 30, 2018 | $497.44M | Aug 15, 2019 |
| FY2018 | Feb 1, 2018 | $112.85M | Aug 16, 2018 |
| FY2018 | Jun 30, 2017 | $380.85M | Aug 16, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 27, 2025 | $181.90M | Aug 11, 2025 |
| FY2025 | Jun 28, 2024 | $219.80M | Aug 11, 2025 |
| FY2024 | Jun 30, 2023 | $357.44M | Aug 13, 2024 |
| FY2023 | Jul 1, 2022 | $385.77M | Aug 15, 2023 |
| FY2022 | Jul 2, 2021 | $374.50M | Aug 16, 2022 |
| FY2021 | Jul 3, 2020 | $312.46M | Aug 17, 2021 |
| FY2020 | Jun 30, 2019 | $226.74M | Aug 18, 2020 |
| FY2019 | Jun 30, 2018 | $179.97M | Aug 15, 2019 |
| FY2018 | Jun 30, 2017 | $139.09M | Aug 16, 2018 |
| FY2017 | Jun 30, 2016 | $114.21M | Aug 18, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 27, 2025 | $309.10M | Aug 11, 2025 |
| FY2025 | Jun 28, 2024 | $180.52M | Aug 11, 2025 |
| FY2024 | Jun 30, 2023 | $71.56M | Aug 13, 2024 |
| FY2023 | Jul 1, 2022 | $65.65M | Aug 15, 2023 |
| FY2022 | Jul 2, 2021 | $113.84M | Aug 16, 2022 |
| FY2021 | Jul 3, 2020 | $226.84M | Aug 17, 2021 |
| FY2020 | Jun 30, 2019 | $257.93M | Aug 18, 2020 |
| FY2019 | Jun 30, 2018 | $66.52M | Aug 15, 2019 |
| FY2019 | Jun 30, 2017 | $41.64M | Aug 15, 2019 |
| FY2019 | Jun 30, 2016 | $81.69M | Aug 15, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Jun 30, 2016 | $192.28M | Aug 16, 2016 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 27, 2025 | 0 | Aug 11, 2025 |
| FY2025 | Jun 28, 2024 | (2) | Aug 11, 2025 |
| FY2025 | Jun 30, 2023 | 0 | Aug 11, 2025 |
| FY2024 | Jul 1, 2022 | 0 | Aug 13, 2024 |
| FY2021 | Jul 2, 2021 | 0 | Aug 17, 2021 |
| FY2021 | Apr 2, 2021 | 0 | Aug 17, 2021 |
| FY2021 | Jan 1, 2021 | 0 | Aug 17, 2021 |
| FY2021 | Oct 2, 2020 | 0 | Aug 17, 2021 |
| FY2021 | Jul 3, 2020 | 0 | Aug 17, 2021 |
| FY2021 | Mar 27, 2020 | 0 | Aug 17, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 27, 2025 | 0 | Aug 11, 2025 |
| FY2025 | Jun 28, 2024 | (2) | Aug 11, 2025 |
| FY2025 | Jun 30, 2023 | 0 | Aug 11, 2025 |
| FY2024 | Jul 1, 2022 | 0 | Aug 13, 2024 |
| FY2021 | Jul 2, 2021 | 0 | Aug 17, 2021 |
| FY2021 | Apr 2, 2021 | 0 | Aug 17, 2021 |
| FY2021 | Jan 1, 2021 | 0 | Aug 17, 2021 |
| FY2021 | Oct 2, 2020 | 0 | Aug 17, 2021 |
| FY2021 | Jul 3, 2020 | 0 | Aug 17, 2021 |
| FY2021 | Mar 27, 2020 | 0 | Aug 17, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 27, 2025 | 59.00M | Aug 11, 2025 |
| FY2025 | Jun 28, 2024 | 58.09M | Aug 11, 2025 |
| FY2024 | Jun 30, 2023 | 56.96M | Aug 13, 2024 |
| FY2023 | Jul 1, 2022 | 55.68M | Aug 15, 2023 |
| FY2022 | Jul 2, 2021 | 55.24M | Aug 16, 2022 |
| FY2021 | Jul 3, 2020 | 54.25M | Aug 17, 2021 |
| FY2020 | Jun 30, 2019 | 54.25M | Aug 18, 2020 |
| FY2019 | Jun 30, 2018 | 46.30M | Aug 15, 2019 |
| FY2018 | Jun 30, 2017 | 46.30M | Aug 16, 2018 |
| FY2017 | Jun 30, 2016 | 38.68M | Aug 18, 2017 |